Pathway Financial Advisers’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-276
Closed -$21.6K 254
2024
Q4
$21.6K Hold
276
0.01% 301
2024
Q3
$25.9K Hold
276
0.01% 229
2024
Q2
$21.5K Hold
276
0.01% 280
2024
Q1
$25.1K Sell
276
-69
-20% -$5.74K 0.01% 282
2023
Q4
$26.7K Hold
345
0.01% 274
2023
Q3
$23.5K Buy
+345
New +$25.1K 0.01% 278
2023
Q1
$28.3K Buy
+345
New +$24.6K 0.01% 271

Other funds holding GEHC

Pathway Financial Advisers's GEHC Position: Q1 2025 in Review

Pathway Financial Advisers sold out of GE HealthCare (GEHC) in Q1 2025, closing a stake of 276 shares — an estimated $21.6K sold.

Pathway Financial Advisers first reported a position in GEHC in Q1 2023 and held it in 7 quarters. The position peaked at $28.3K in Q1 2023. 1,371 funds tracked by Wall St. Rank hold GEHC as of Q1 2025.

  • Pathway Financial Advisers reported no remaining GE HealthCare position as of Q1 2025 after selling out during the quarter.
  • Pathway Financial Advisers sold 276 GE HealthCare shares in Q1 2025, an estimated $21.6K.
  • Pathway Financial Advisers first reported a position in GE HealthCare in Q1 2023 and held it in 7 quarters.
  • Pathway Financial Advisers's GE HealthCare position peaked at $28.3K in Q1 2023.
  • 1,371 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2025.

Based on Pathway Financial Advisers's 13F filing for Q1 2025, filed 9 May 2025.